Table 1.
Model* | Overexpression | siRNA | UCP2−/− mouse (liver) |
---|---|---|---|
Basal mitochondrial Ca2+ | Unchanged | Unchanged | n.d. |
Mitochondrial Ca2+ uptake | Increased (even under de-polarized conditions) | Strongly reduced (rescue by UCP2 in UCP3 cells treated with siRNA against UCP3) | Absent (no ruthenium red-sensitive Ca2+ entry) |
Capacity of the MCU | Increased (even under depolarized conditions) | Strongly reduced | Reduced |
Ca2+ sensitivity of MCU | Unchanged | n.d. | n.d. |
Basal Δψmito | Unchanged | Unchanged | Unchanged |
Δψmito upon stimulation/Ca2+ exposure | Unchanged | Unchanged | Unchanged |
Basal pHmito | Unchanged | Unchanged | n.d. |
pHmito upon stimulation | Decreased due to elevated [Ca2+]mito | Unchanged | n.d. |
Basal ATP levels | Unchanged | n.d. | n.d. |
ATP synthesis | Increased | n.d. | n.d. |
Basal cytosolic Ca2+ concentration | Unchanged | Unchanged | n.d. |
Intracellular Ca2+ mobilization | Unchanged | Unchanged | n.d. |
Mitochondrial structure | Unchanged | Unchanged | n.d. |
Focal contacts with the ER | Unchanged | Unchanged | n.d. |
ER Ca2+ content | Unchanged | Unchanged | n.d. |
Most experiments were performed in human endothelial cells but were verified in HeLa, Hek293 and CHO cells.